Table 2.
Demographic and clinical characteristics for survival status.
| Variables | Alive (n=214) | Dead (n=36) | P-value | ||
|---|---|---|---|---|---|
| Age (years) | 71.7±11.8 | 75.9±11.4 | 0.049† | ||
| Gender | 0.959‡ | ||||
| Female | 106 | (49.5) | 18 | (50) | |
| Male | 108 | (50.5) | 18 | (50) | |
| Latency | 8 (2-120) | 5 (2-72) | 0.008¶ | ||
| NIHSS | 4.5 (1-16) | 14 (4-18) | <0.001¶ | ||
| TOAST | <0.001$ | ||||
| Large artery disease | 22 | (10.3) | - | ||
| Cardioembolism | 27 | (12.6) | 2 | (5.6) | |
| Small artery disease (lacune) | 40 | (18.7) | - | ||
| Stroke of other determined | - | - | |||
| Undetermined | 125 | (58.4) | 34 | (94.4) | 0.494¶ |
| Hospitalization days | 4 (1-36) | 4 (1-116) | 0.842¶ | ||
| TIV(h) | 4.3±9.8 | 2.1±3.9 | 0.549 | ||
| MPV (mean) | 8.5 (4.4-13.4) | 8.9 (4.8-15.7) | |||
†
Student’s t-test,
‡
Pearson’s Chi-square test,
¶
Mann-Whitney U test,
$
Likelihood ratio test, NIHSS - National Institutes of Health Stroke Scale, TOAST - The Trial Of Org 10172 in Acute Stroke Treatment, TIV - time interval of venipuncture